Do you want to read an article? Please log in or register.
Dysregulation of prostaglandins, leukotrienes and lipoxin A4 in bronchiectasis
Bronchi
RECOMMENDED
Related content
RECOMMENDED
Bronchi
Inhaled liposomal ciprofloxacin in patients with non-cystic fibrosis bronchiectasis and chronic lung infection with Pseudomonas aeruginosa (ORBIT-3 and ORBIT-4): two phase 3, randomised controlled trials
Lancet Respir Med.
Haworth CS, Bilton D, Chalmers JD, Davis AM, Froehlich J, Gonda I, Thompson B, Wanner A, O'Donnell AE
doi: 10.1016/S2213-2600(18)30427-2.
RECOMMENDED
Further Publications
Pseudomonas aeruginosa associated with severity of non-cystic fibrosis bronchiectasis measured by the modified bronchiectasis severity score (BSI) and the FACED: The US bronchiectasis and NTM Research Registry (BRR) study
★ 1
Recommended by
Dr Martin Frey, Faculty Member
★ 2
Recommended by
Dr Marcus Hesse, Faculty Member
Respir Med
Choate R, Aksamit TR, Mannino D, Addrizzo-Harris D, Barker A, Basavaraj A, Daley CL, Daniels MLA, Eden E, DiMango A, Fennelly K, Griffith DE, Johnson MM, Knowles MR, McShane PJ, Metersky ML, Noone PG, O'Donnell AE, Olivier KN, Salathe MA, Schmid A, Thomashow B, Tino G, Winthrop KL, Stone G
doi: 10.1016/j.rmed.2020.106285
RECOMMENDED
Bronchi
A comprehensive approach to lung function in bronchiectasis
Respir Med.
Radovanovic D, Santus P, Blasi F, Sotgiu G, D'Arcangelo F, Simonetta E, Contarini M, Franceschi E, Goeminne PC, Chalmers JD, Aliberti S
doi: 10.1016/j.rmed.2018.10.031.
RECOMMENDED
Bronchi
Paediatric and adult bronchiectasis: Monitoring, cross-infection, role of multidisciplinary teams and self-management plans
Respirology.
Navaratnam V, Forrester DL, Eg KP, Chang AB
doi: 10.1111/resp.13451.
RECOMMENDED
Asthma
Urinary Leukotriene E4 and Prostaglandin D2 Metabolites Increase in Adult and Childhood Severe Asthma Characterized by Type-2 Inflammation
★ 3
Recommended by
Dr Martin Frey, Faculty Member
Am J Respir Crit Care Med.
Kolmert J, Gómez C, Balgoma D, Sjödin M, Bood J, Konradsen JR, Ericsson M, Thörngren JO, James A, Mikus M, Sousa AR, Riley JH, Bates S, Bakke PS, Pandis I, Caruso M, Chanez P, Fowler SJ, Geiser T, Howarth P, Horváth I, Krug N, Montuschi P, Sanak M, Behndig A, Shaw DE, Knowles RG, Holweg CTJ, Wheelock ÅM, Dahlén B, Nordlund B, Alving K, Hedlin G, Chung KF, Adcock IM, Sterk PJ, Djukanovic R, Dahlén SE, Wheelock CE, U-BIOPRED Study Group
doi: 10.1164/rccm.201909-1869OC.
RECOMMENDED
COPDBronchi
Pulmonary rehabilitation in bronchiectasis: a propensity matched study
Eur Respir J.
Patel S, Cole AD, Nolan CM, Barker RE, Jones SE, Kon S, Cairn J, Loebinger M, Wilson R, Man WD
doi: 10.1183/13993003.
RECOMMENDED
Bronchi
Antimicrobial peptides, disease severity and exacerbations in bronchiectasis
Thorax.
Sibila O, Perea L, Cantó E, Shoemark A, Cassidy D, Smith AH, Suarez-Cuartin G, Rodrigo-Troyano A, Keir HR, Oriano M, Ong S, Vidal S, Blasi F, Aliberti S, Chalmers JD
doi: 10.1136/thoraxjnl-2018-212895.
RECOMMENDED
COPD
Relationship between clinical and radiological signs of bronchiectasis in COPD patients: Results from COSYCONET
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Respir Med.
Kahnert K, Jörres RA, Kauczor HU, Biederer J, Jobst B, Alter P, Biertz F, Mertsch P, Lucke T, Lutter JI, Trudzinski FC, Behr J, Bals R, Watz H, Vogelmeier CF, Welte T, COSYCONET Study-Group., Names of participating study nurses.
doi: 10.1016/j.rmed.2020.106117.
RECOMMENDED
Bronchi
Systemic Inflammation during and after Bronchiectasis Exacerbations: Impact of Pseudomonas aeruginosa
★ 1
Recommended by
Dr Martin Frey, Faculty Member
J Clin Med.
Menéndez R, Méndez R, Amara-Elori I, Reyes S, Montull B, Feced L, Alonso R, Amaro R, Alcaraz V, Fernandez-Barat L, Torres A
doi: 10.3390/jcm9082631.